In a market moving as quickly as AI, investors say that they aren't looking for companies with technology moats, but rather ...

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

Bengaluru-based payment solutions provider Juspay is in discussions with Warburg Pincus, Kedaara Capital, and Norwest Venture ...

Providence launched its venture arm in 2015. Allumia focuses on health care tech and originally managed funds only for ...

Private-equity veteran Richard Lichter launched Causeway Equity Partners, looking to capitalize on the growing numbers of ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. | The Fierce Biotech Fundraising Tracker records ...

2025 will be the year of personalized health data. For women, this shift is especially significant. Hormonal data will ...

The so-called AI boom has been going on for more than two years now, and 2024 saw a real acceleration in both the development ...

US venture capital firm Accel, which has backed a slew of unicorns in India including Flipkart and Swiggy, has mopped up $650 million (approximately Rs 5,500 crore) for its eighth India fund, show ...

Venture Intelligence reports $31.1 Billion PE-VC investments in Indian companies in 2024, slightly lower than 2023 figures.